Alien Registration- Mccarron, Mary E. (Brewer, Penobscot County)

https://digitalmaine.com/alien_docs/10707/thumbnail.jp

Assessing A National Nanotechnology Infrastructure For Enforcing Nanosafety In Consumer Food - Funding The Infrastructure

. Crucial to assessing any national risk assessment infrastructure is the development of keen insights into the funding landscape, the base skill set and expertise levels, risk prioritisation, and stakeholder determination. This paper presents an overview of the first of these criteria with respect to the Irish funding landscape for nanotechnology and nano-agri-food. It examines difficulties with policy enforcement due to a lack of clarity and varying interpretations of the EU definition of nanomaterials and how the funding landscape could potentially facilitate the necessary infrastructure, to underpin regulatory enforcement and risk assessment for nanotechnology in food. In 2008 an assessment of the potential risks associated with nanotechnologies was carried out in Ireland which resulted in a number of recommendations centred around the provision of funding. This study examines Exchequer/public investment over the last decade to develop research infrastructure and it identifies if such investment has helped enhance the enforcement of nano-food safety legislation in Ireland

The transition of smooth muscle cells from a contractile to a migratory, phagocytic phenotype : direct demonstration of phenotypic modulation

Atherosclerotic plaques are populated with smooth muscle cells (SMCs) and macrophages. SMCs are thought to accumulate in plaques because fully-differentiated, contractile SMCs reprogram into a ‘synthetic’ migratory phenotype, so-called phenotypic modulation, whilst plaque macrophages are thought to derive from blood-borne myeloid cells. Recently, these views have been challenged, with reports that SMC phenotypic modulation may not occur during vascular remodelling and that plaque macrophages may not be of haematopoietic origin. Following the fate of SMCs is complicated by the lack of specific markers for the migratory phenotype and direct demonstrations of phenotypic modulation are lacking. Therefore, we employed long-term, high-resolution, time-lapse microscopy to track the fate of unambiguously identified, fully-differentiated, contractile SMCs in response to the growth factors present in serum. Phenotypic modulation was clearly observed. The highly-elongated, contractile SMCs initially rounded up, for 1-3 days, before spreading outwards. Once spread, the SMCs became motile and displayed dynamic cell-cell communication behaviours. Significantly, they also displayed clear evidence of phagocytic activity. This macrophage-like behaviour was confirmed by their internalisation of 1µm fluorescent latex beads. However, migratory SMCs did not uptake acetylated low-density lipoprotein or express the classic macrophage marker CD68. These results directly demonstrate that SMCs may rapidly undergo phenotypic modulation and develop phagocytic capabilities. Resident SMCs may provide a potential source of macrophages in vascular remodelling